{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:54:34Z","timestamp":1790830474863,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jad.2026.122421","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:56:43Z","timestamp":1788278203000},"page":"122421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The effect of vortioxetine on cognitive function in older adults with major depressive disorder: A systematic review"],"prefix":"10.1016","volume":"415","author":[{"given":"Muhammad","family":"El-Kassem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Tarek","family":"Madani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad R.","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Elhusein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco De Tubino","family":"Scanavino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Adil Shah","family":"Khoodoruth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verinder","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Makki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.122421_bb0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1176\/appi.ajp.20230392","article-title":"Cognitive outcomes after antidepressant pharmacotherapy for late-life depression: a systematic review and Meta-analysis","volume":"181","author":"Ainsworth","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122421_bb0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41398-019-0514-6","article-title":"Mechanisms and treatment of late-life depression","volume":"9","author":"Alexopoulos","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2026.122421_bb0015","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/jm101459g","article-title":"Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder","volume":"54","author":"Bang-Andersen","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jad.2026.122421_bb0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ijnp\/pyx070","article-title":"A network Meta-analysis comparing effects of various antidepressant classes on the digit symbol substitution test (DSST) as a measure of cognitive dysfunction in patients with major depressive disorder","volume":"21","author":"Baune","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122421_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211026796","article-title":"Cognitive effects of vortioxetine in older adults: a systematic review","volume":"11","author":"Bishop","year":"2021","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122421_bb0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/cjn.2015.399","article-title":"Depressive symptoms negatively impact Montreal cognitive assessment performance: a memory clinic experience","volume":"43","author":"Blair","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jad.2026.122421_bb0035","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r13200","article-title":"Procognitive effects of antidepressants and other therapeutic agents in major depressive disorder: a systematic review","volume":"81","author":"Blumberg","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122421_bb0040","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/jcpt.13177","article-title":"Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: a double-blind randomized trial","volume":"45","author":"Borhannejad","year":"2020","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.jad.2026.122421_bb0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jad.2023.06.024","article-title":"Effectiveness of vortioxetine in patients with major depressive disorder and early-stage dementia: the MEMORY study","volume":"338","author":"Christensen","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122421_bb0050","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1017\/S0033291710001911","article-title":"Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study","volume":"41","author":"Conradi","year":"2011","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2026.122421_bb0055","unstructured":"Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia [WWW Document], n.d.. Covidence. URL https:\/\/www.covidence.org\/ (accessed 2.15.25)."},{"key":"10.1016\/j.jad.2026.122421_bb0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.14283\/jpad.2019.24","article-title":"Treatment effects of Vortioxetine on cognitive functions in mild Alzheimer\u2019s disease patients with depressive symptoms: a 12 month, open-label, observational study","volume":"6","author":"Cumbo","year":"2019","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.jad.2026.122421_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1037816","article-title":"Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer\u2019s disease in routine clinical practice: an analysis of a post-marketing surveillance study in South Korea","volume":"14","author":"Cumbo","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jad.2026.122421_bb0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/14740338.2022.2019705","article-title":"Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review","volume":"21","author":"De Diego-Adeli\u00f1o","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jad.2026.122421_bb0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/02698811241260996","article-title":"Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: results from the RELIEVE study","volume":"38","author":"Di Nicola","year":"2024","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.jad.2026.122421_bb0080","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1523\/JNEUROSCI.2999-05.2005","article-title":"Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action","volume":"25","author":"D\u00edaz-Mataix","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jad.2026.122421_bb0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2016.05.029","article-title":"A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex","volume":"786","author":"Du Jardin","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jad.2026.122421_bb0090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jad.2021.02.075","article-title":"Safety and efficacy of vortioxetine on depressive symptoms and cognition in post-stroke patients: a pilot study","volume":"286","author":"Gamberini","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122421_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/jpm14090918","article-title":"Effectiveness of vortioxetine treatment on depression and cognitive functions in patients with Alzheimer\u2019s disease: a 12-month, retrospective, observational study","volume":"14","author":"Garc\u00eda-Alberca","year":"2024","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.jad.2026.122421_bb0100","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122421_bb0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.9758\/cpn.2022.20.2.311","article-title":"Vortioxetine treatment for depression in Alzheimer\u2019s disease: a randomized, double-blind, placebo-controlled study","volume":"20","author":"Jeong","year":"2022","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jad.2026.122421_bb0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/YIC.0b013e3283542457","article-title":"A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder","volume":"27","author":"Katona","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.122421_bb0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1017\/S1355617714000198","article-title":"Cognitive functioning and late-life depression","volume":"20","author":"Koenig","year":"2014","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.jad.2026.122421_bb0120","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/070674371405901206","article-title":"Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment","volume":"59","author":"Lam","year":"2014","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2026.122421_bb0125","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1176\/appi.ajp.2019.19050561","article-title":"Augmenting computerized cognitive training with Vortioxetine for age-related cognitive decline: a randomized controlled trial","volume":"177","author":"Lenze","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122421_bb0130","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/cercor\/bhr220","article-title":"5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons","volume":"22","author":"Llad\u00f3-Pelfort","year":"2012","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.jad.2026.122421_bb0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jad.2026.122421_bb0140","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw055","article-title":"The effects of Vortioxetine on cognitive function in patients with major depressive disorder: a Meta-analysis of three randomized controlled trials","volume":"19","author":"McIntyre","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122421_bb0145","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1017\/S1461145714000546","article-title":"A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults","volume":"17","author":"McIntyre","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122421_bb0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12888-023-04554-w","article-title":"Cognitive rehabilitation for improving cognitive functions and reducing the severity of depressive symptoms in adult patients with major depressive disorder: a systematic review and meta-analysis of randomized controlled clinical trials","volume":"23","author":"Mokhtari","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2026.122421_bb0155","article-title":"Safety and effectiveness of vortioxetine for major depressive disorder: real-world evidence from a population-based study in South Korea","volume":"14","author":"Moon","year":"2023","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.122421_bb0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3928\/00485713-20140306-05","article-title":"Cognitive impairment in depressed older adults: implications for prognosis and treatment","volume":"44","author":"Morimoto","year":"2014","journal-title":"Psychiatr. Ann."},{"key":"10.1016\/j.jad.2026.122421_bb0165","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jagp.2024.08.015","article-title":"A systematic review of antidepressants and psychotherapy commonly used in the treatment of late life depression for their effects on cognition","volume":"33","author":"Nelson","year":"2025","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2026.122421_bb0170","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s43440-023-00448-6","article-title":"Agonistic properties of a series of psychotropic drugs at 5-HT1A receptors in rat and human brain membranes determined by [35S]GTP\u03b3S binding assay","volume":"75","author":"Odagaki","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jad.2026.122421_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102491","article-title":"Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial","volume":"69","author":"Ostuzzi","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jad.2026.122421_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2021.104457","article-title":"Mental health, resilience, and religiosity in the elderly under COVID-19 quarantine in Qatar","volume":"96","author":"Ouanes","year":"2021","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.jad.2026.122421_bb0185","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122421_bb0190","article-title":"Prediction of antidepressant efficacy by cognitive function in first-episode late-life depression: a pilot study","volume":"13","author":"Pan","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.122421_bb0195","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s11920-012-0322-7","article-title":"Where in the brain is depression?","volume":"14","author":"Pandya","year":"2012","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2026.122421_bb0200","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jpsychires.2008.06.002","article-title":"The MMSE is not an adequate screening cognitive instrument in studies of late-life depression","volume":"43","author":"Rajji","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.122421_bb0205","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1017\/S003329170800411X","article-title":"Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis","volume":"39","author":"Reppermund","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2026.122421_bb0210","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1017\/S0033291713002535","article-title":"Cognitive impairment in depression: a systematic review and meta-analysis","volume":"44","author":"Rock","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2026.122421_bb0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pharmthera.2014.07.001","article-title":"Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data","volume":"145","author":"Sanchez","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jad.2026.122421_bb0220","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2215-0366(19)30291-3","article-title":"Cognitive function following a major depressive episode: a systematic review and meta-analysis","volume":"6","author":"Semkovska","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.122421_bb0225","first-page":"431","article-title":"Screening for cognitive impairment in primary care: rationale and tools","volume":"120","author":"Siddiqui","year":"2023","journal-title":"Mo. Med."},{"key":"10.1016\/j.jad.2026.122421_bb0230","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122421_bb0235","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122421_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/npr2.70023","article-title":"Augmentation therapy with serotonin 5-HT1A receptor partial agonists on cognitive function in depressive disorders: a systematic review of randomized controlled studies","volume":"45","author":"Yamada","year":"2025","journal-title":"Neuropsychopharmacol. Rep."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726012747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726012747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:54:55Z","timestamp":1790826895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726012747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":48,"alternative-id":["S0165032726012747"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122421","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of vortioxetine on cognitive function in older adults with major depressive disorder: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122421"}}